Market Cap ₹55 Cr.
Stock P/E 14.2
P/B 1.5
Current Price ₹40.3
Book Value ₹ 26.6
Face Value 10
52W High ₹45.1
Dividend Yield 0%
52W Low ₹ 34.1
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|
Net Sales | 12 | 17 | 17 | 21 | |
Other Income | 1 | 1 | 17 | 3 | |
Total Income | 13 | 18 | 35 | 23 | |
Total Expenditure | 3 | 8 | 19 | 12 | |
Operating Profit | 10 | 10 | 15 | 12 | |
Interest | 4 | 4 | 3 | 3 | |
Depreciation | 5 | 5 | 4 | 4 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
Profit Before Tax | 1 | 1 | 8 | 5 | |
Provision for Tax | 0 | 0 | 1 | 1 | |
Profit After Tax | 0 | 1 | 7 | 4 | |
Adjustments | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 0 | 1 | 7 | 4 | |
Adjusted Earnings Per Share | 0.3 | 0.9 | 7 | 3.9 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 24% | 21% | 0% | 0% |
Operating Profit CAGR | -20% | 6% | 0% | 0% |
PAT CAGR | -43% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | NA% | NA% | NA% |
ROE Average | 21% | 29% | 23% | 23% |
ROCE Average | 19% | 19% | 17% | 17% |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Shareholder's Funds | 8 | 9 | 16 | 20 |
Minority's Interest | 0 | 0 | 0 | 0 |
Borrowings | 30 | 26 | 20 | 14 |
Other Non-Current Liabilities | 1 | 1 | 1 | 1 |
Total Current Liabilities | 9 | 16 | 10 | 11 |
Total Liabilities | 49 | 53 | 47 | 46 |
Fixed Assets | 13 | 12 | 10 | 10 |
Other Non-Current Assets | 23 | 26 | 17 | 10 |
Total Current Assets | 13 | 15 | 20 | 26 |
Total Assets | 49 | 53 | 47 | 46 |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 |
Cash Flow from Operating Activities | 4 | 18 | 4 | 7 |
Cash Flow from Investing Activities | -2 | -11 | 7 | 2 |
Cash Flow from Financing Activities | -2 | -7 | -11 | -9 |
Net Cash Inflow / Outflow | 0 | 0 | -0 | 0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 1 |
# | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Earnings Per Share (Rs) | 0.34 | 0.87 | 7.04 | 3.86 |
CEPS(Rs) | 5.56 | 6.21 | 11.29 | 7.71 |
DPS(Rs) | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 8.23 | 9.1 | 16.14 | 20 |
Core EBITDA Margin(%) | 77.02 | 53.52 | -10.98 | 44.32 |
EBIT Margin(%) | 42.05 | 29.92 | 63.97 | 38.13 |
Pre Tax Margin(%) | 5.71 | 7.05 | 44.53 | 24.94 |
PAT Margin (%) | 2.79 | 5.03 | 40.28 | 18.47 |
Cash Profit Margin (%) | 45.3 | 36.05 | 64.57 | 36.91 |
ROA(%) | 0.7 | 1.71 | 14.11 | 8.33 |
ROE(%) | 4.16 | 9.99 | 55.79 | 21.35 |
ROCE(%) | 11.22 | 11.52 | 25.98 | 19.17 |
Receivable days | 344.73 | 210.24 | 156.68 | 123.84 |
Inventory Days | 1.04 | 0.74 | 0.73 | 0.6 |
Payable days | 3219.23 | 208.9 | 82.69 | 733.82 |
PER(x) | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 |
Dividend Yield(%) | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 3.22 | 2.09 | 1.62 | 1.43 |
EV/Core EBITDA(x) | 3.81 | 3.44 | 1.84 | 2.52 |
Net Sales Growth(%) | 0 | 40.23 | 1.57 | 19.47 |
EBIT Growth(%) | 0 | -0.22 | 117.17 | -28.78 |
PAT Growth(%) | 0 | 152.61 | 712.85 | -45.21 |
EPS Growth(%) | 0 | 152.61 | 712.85 | -45.21 |
Debt/Equity(x) | 4.58 | 3.77 | 1.64 | 1.02 |
Current Ratio(x) | 1.36 | 0.91 | 1.97 | 2.43 |
Quick Ratio(x) | 1.35 | 0.91 | 1.96 | 2.42 |
Interest Cover(x) | 1.16 | 1.31 | 3.29 | 2.89 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
# | Dec 2024 | Mar 2025 |
---|---|---|
Promoter | 73.5 | 73.5 |
FII | 0 | 0 |
DII | 0 | 0 |
Public | 26.5 | 26.5 |
Others | 0 | 0 |
Total | 100 | 100 |
# | Dec 2024 | Mar 2025 |
---|---|---|
Promoter | 1 | 1 |
FII | 0 | 0 |
DII | 0 | 0 |
Public | 0.36 | 0.36 |
Others | 0 | 0 |
Total | 1.36 | 1.36 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About